This website is intended for healthcare professionals only.

Newsletter      
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

European Society of Cardiology – Updated valvular heart disease guidelines 2021

In August, new guidelines were released as part of the ESC Congress 2021 for the management of valvular heart disease.

READ MORE
tavi efficiency

TAVI efficiency programs: Optimised TAVI pathways

Rapid expansion in the use of TAVI has led to continuing improvements in techniques and clinical outcomes, but this has also presented a new problem: treating a larger cohort of patients in a more efficient way with shorter procedures and shorter hospital stays, while maintaining excellent outcomes. Optimised TAVI approaches have been shown to have distinct advantages without compromising patient safety.

READ MORE

Optimising organisational efficiencies in the treatment of patients with ssAS

The TAVI approach is a driver for organisational benefits, including shorter waiting lists, cuts to procedural times, increase in hospital capacity and shorter length of hospital stay.

VIEW NOW

STAY UP TO DATE

Subscribe

OR GET IN TOUCH TO LEARN MORE

Monthly Expert opinion

The benefits from optimising the TAVI procedure has been in the post-procedure phase. Reducing patients’ length of stay has made the patients’ recovery easier and, amidst the pandemic, TAVI efficiencies are less resource intensive. We perform 3-4 procedures a day, compared with 1-2 surgical procedures a day. These benefits are important post-COVID19 recovery and enable us to reduce waiting lists and the backlog of care.

Patients are interested in TAVI, since it’s perceived as less scary than an invasive cardiac surgical procedure with quicker recovery, However, it is not as simple as TAVI vs SAVR and our multidisciplinary team make that decision. We have three clinical nurse specialists who coordinate TAVI alongside admin staff, cardiologists, and recently, the addition of a geriatrician; the geriatrician offers a holistic view of the patient. 

We hold improvement plan meetings where we utilise our learnings from the Edwards Benchmark Programme: for us, our focus is very much on reducing the strain on high dependency care beds, optimising patient discharge direct to the ward in a safe and timely way.

Future events

13 Jul
Clinical Quality Strategy Forum
27 Aug
ESC Congress 2021 - The Digital Experience Virtual 7:00 am
15 Sep
EHMA Annual Conference
View all events

TAVI Resources

View all resources

European Society of Cardiology – Updated valvular heart disease guidelines 2021

Updated recommendations for the treatment of patients with aortic stenosis can all be found in the new guidelines, released in August, at the ESC Congress 2021.

Impact of COVID-19 on TAVI and the management of patients with severe symptomatic aortic stenosis

During the pandemic, hospitals have initiated protocols that favour management options that minimise the use of anaesthesiologists, ventilators, operating rooms, and intensive care unit beds. TAVI does not require all these elements.

Transcatheter aortic valve implantation efficiency programs: Optimised TAVI pathways

An optimised TAVI pathway embodies efficient patient screening, a minimalist peri-procedure approach and early discharge – eliminating complication risks and without compromising patient outcomes.

TAVI Publications

EuroPCR highlights (18-20 May) Part 3: The Edwards Benchmark™ program

Highlights from EuroPCR 2021 focus on TAVI for aortic stenosis: presentations include TAVI in a before-now excluded patient population, bicuspid aortic stenosis and on the contemporary challenges for TAVI such as expanding patient populations, valve durability and long-term outcome data…

EuroPCR highlights (18-20 May) Part 2: Optimising the TAVI procedure

Highlights from EuroPCR 2021 focus on TAVI for aortic stenosis: presentations include TAVI in a before-now excluded patient population, bicuspid aortic stenosis and on the contemporary challenges for TAVI such as expanding patient populations, valve durability and long-term outcome data…


Key paper evaluations

View more papers

Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes

 

Authors: Lauck S, Forman J, Borregaard B, Sathananthan J, et al.

Citation: Eur J Cardiovasc Nursing. 2020;19:537–44.
doi:10.1177/1474515120934057.

Period of study:

The cost-effectiveness of TAVR in low surgical risk patients with severe aortic stenosis

 

Authors: Tam DY, Azizi PM, Fremes SE, Chikwe J, et al.

Citation: Eur Heart J Qual Care Clin Outcomes. 2020 Jul 9;qcaa058. DOI: 10.1093/ehjqcco/qcaa058.

Period of study:

SCAI/ACVP expert consensus statement on cardiovascular catheterization laboratory economics

 

Authors: Blankenship JC, Choi JW, Das TS, McElgunn PM, et al.

Citation: Catheter Cardiovasc Interv. 2019; 94: 123–35
DOI:10.1002/ccd.28330.

Patient enrolment: May 2015 – October 2017

This content is sponsored by Edwards Lifesciences